• Exchange: Helsinki
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ORNAV:FH

26.5900 EUR 0.2500 0.95%

As of 11:29:59 ET on 07/22/2014.

Snapshot for Orion OYJ (ORNAV)

Open: 26.3200 Day's Range: 26.2800 - 26.5900 Volume: 3,003
Previous Close: 26.3400 52wk Range: 17.4100 - 28.1000 1-Yr Rtn: +44.64%

Stock Chart for ORNAV

No chart data available.
  • ORNAV:FH 26.5900
  • 1D
  • 1M
  • 1Y
26.3400
Interactive ORNAV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORNAV

Current P/E Ratio (ttm) 18.2123
Estimated P/E(12/2014) 18.4269
Relative P/E vs. HEXP 0.6351
Earnings Per Share (EUR) (ttm) 1.4600
Est. EPS (EUR) (12/2014) 1.4430
Est. PEG Ratio -
Market Cap (M EUR) 3,769.90
Shares Outstanding (M) 41.37
30 Day Average Volume 7,993
Price/Book (mrq) 7.2733
Price/Sale (ttm) 3.7237
Dividend Indicated Gross Yield 4.71%
Cash Dividend (EUR) 1.2500
Dividend Ex-Date 03/26/2014
5 Year Dividend Growth 5.64%
Next Earnings Announcement 07/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORNAV

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ORNAV

Orion Oyj develops and manufactures pharmaceuticals and diagnostic kits. The Company produces hormone therapies and drugs to treat central nervous system disorders, cardiovascular diseases and urological disorders, and in vitro diagnostic kits used in doctor's offices and small laboratories.

Hannu SyrjaenenChairmanJukka YlppoVice Chairman
Timo LappalainenPresident/CEOJari KarlsonChief Financial Officer
More Company Profile & Key Executives for ORNAV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil